Results 91 to 100 of about 36,964 (190)

Recent Advances in Conjugation Chemistry Expanding the Applications of the DNA Tetrahedron

Chemical Biology &Drug Design, Volume 108, Issue 2, August 2026.
The tetrahedral DNA nanostructure (TDN) is a promising drug delivery and biosensing platform that can be chemically modified with absolute payload precision. This review highlights explicit conjugation chemistries driving functionalization of the TDN for a broad range of applications, advancing its role in support of next‐generation biomimetic ...
Tyler J. Rutherford, Christopher J. Wilds   +1 more
wiley   +1 more source

A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity–ECOG–Age criteria

British Journal of Haematology, Volume 209, Issue 2, Page 809-811, August 2026.
Daniel Weidl, Myrto Boukovala, Doris Glaser, Bettina Barthel, Lars Bullinger, Michael Heuser   +5 more
wiley   +1 more source

Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo

International Journal of Nanomedicine, 2016
Yi Zhou,1,2 Ruju Wang,1 Bing Chen,1 Dan Sun,3 Yong Hu,2 Peipei Xu1 1Department of Hematology, Drum Tower Hospital, School of Medicine, 2Institute of Materials Engineering and Collaborative Innovation Center of Chemistry for Life Sciences, College of ...
Zhou Y, Wang R, Chen B, Sun D, Hu Y, Xu P   +5 more
doaj  

Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer

International Journal of Nanomedicine, 2019
Yuanyuan Wang,1 Min Fu,2 Jingjing Liu,2 Yining Yang,1 Yibin Yu,1 Jinyu Li,1 Weisan Pan,1 Lei Fan,3 Guiru Li,4 Xuetao Li,2 Xiaobo Wang1,31Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, People’s Republic of China;
Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X   +10 more
doaj  

DNA-intercalating antiphage molecules trigger abortive infection through mutual destruction and synergize with bacterial immunity. [PDF]

Proc Natl Acad Sci U S A
Ernst L, Gätgens C, Rackow B, Pozhydaieva N, Gaaloul E, Krüger A, Seiffarth J, Bund M, Joisten-Rosenthal V, Kohlheyer D, Usadel B, Harms A, Höfer K, Frunzke J.   +13 more
europepmc   +1 more source

Post-marketing safety evaluation of anthracycline for acute myeloid leukemia treatment: a real-world pharmacovigilance analysis. [PDF]

Front Pharmacol
Wang Y, Liu Q, Xu J, Yang F, Wang M, Lu H, Wu J, Zhang A, Zhang X, Wu D, Qiu H.   +10 more
europepmc   +1 more source

Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations. [PDF]

Cureus
Sapkota S, Alshaikhli A, Shah N, Nepal A, Kulkarni A, Bhandari P, Sapkota S, Kenmoe J, Bayya M, Shrotriya S, Sharma S.   +10 more
europepmc   +1 more source

Reversal Effects of 20(R)- and 20(S)-Ginsenoside-Rg3 on Daunorubicin Uptake in Multidrug-Resistant Leukemia Cells Studied in the Single-Cell Biochip. [PDF]

Int J Mol Sci
Chen Y, Joshi N, Chiem M, Kolesnyk I, Li PCH, Yue PYK, Wong RNS.   +6 more
europepmc   +1 more source

Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice. [PDF]

Support Care Cancer
Ditta SA, Jongbloed F, Manintveld OC, Brugma JD, Wlazlo N, Bos MEMM, van der Kuy HM, Mathijssen RHJ.   +7 more
europepmc   +1 more source

Case Report: Juvenile dermatomyositis complicated by acute myeloid leukemia: achievement of sustained remission through hematopoietic stem cell transplantation. [PDF]

Front Immunol
Fu P, Chen K, Liu Q, Zou B, Wang Z, Wang D, Jiang H, Zhang N, Shao J.   +8 more
europepmc   +1 more source